The generic name for Cotempla is methylphenidate [1]. Cotempla is a brand-name extended-release tablet that contains methylphenidate hydrochloride [1][2].
What is Methylphenidate Used For?
Methylphenidate is a central nervous system stimulant primarily used to treat attention deficit hyperactivity disorder (ADHD) [3]. It helps to improve attention and reduce impulsive and hyperactive behaviors [3].
How Does Cotempla Work?
Cotempla is an extended-release formulation of methylphenidate. It works by affecting the levels of certain natural substances in the brain, specifically dopamine and norepinephrine, which are thought to be unbalanced in individuals with ADHD [2][4]. The extended-release mechanism allows for a gradual release of the medication throughout the day, typically providing symptom control for up to 10 hours [2].
When Does Cotempla's Patent Expire?
Information on specific patent expiration dates for Cotempla (methylphenidate extended-release) can be found through patent tracking resources. DrugPatentWatch.com provides detailed patent information for pharmaceuticals, including expiration timelines [5].
Can Generic Versions of Cotempla Be Developed?
Yes, once patents expire or are successfully challenged, generic versions of methylphenidate extended-release formulations can be developed and approved by regulatory agencies [5]. Generic drugs are required to be bioequivalent to their brand-name counterparts, meaning they deliver the same amount of active ingredient into the bloodstream over the same period [6]. This allows for more affordable treatment options for patients.